InsiderClue
Insiders · Profile

Gerberding Julie L.

EVP, Chief Patient Officer at Merck. Filing since 8 May 2015. CIK 0001628884

Company
Date
Role
Action
Shares
Amount
Of holding
MRK Merck & Co.
1 Nov 2021
EVP, Chief Patient Officer
Sold, plan not stated
96,270
$8.46M
71.1%
MRK Merck & Co.
17 Jul 2020
EVP Strat Comm, GI Pub Policy
Sold, plan not stated
36,285
$2.90M
57.7%
MRK Merck & Co.
13 Jan 2020
EVP Strat Comm, GI Pub Policy
Sold, plan not stated
102,073
$9.12M
73.4%
MRK Merck & Co.
7 Nov 2018
EVP Strat Comm, Gl Pub Policy
Sold, plan not stated
36,218
$2.72M
43.9%
MRK Merck & Co.
15 May 2018
EVP Strat Comm, Gl Pub Policy
Sold, plan not stated
9,972
$594.96K
17.9%
MRK Merck & Co.
7 Nov 2016
EVP Strat Comm, Gl Pub Policy
Sold, plan not stated
85,523
$5.13M
68.6%
MRK Merck & Co.
8 May 2015
EVP Strat Comm, Gl Pub Policy
Sold, plan not stated
38,368
$2.34M
54.5%
7 decisions on file.